Akifumi Muramoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akifumi Muramoto has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Motohiro Kobayashi
Department of Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan
4 shared publications - Tomoya O. Akama
Department of Pharmacology, Kansai Medical University, Hirakata, Japan
3 shared publications - Eiichi Kato
Division of Otorhinolaryngology—Head and Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Sciences University of Fukui Fukui Japan
2 shared publications - Naoki Terada
Department of Urology University of Fukui Fukui Japan
2 shared publications Natsumi Yonemoto
Department of Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan
2 shared publications- Yoshiaki Imamura
Division of Diagnostic Pathology/Surgical Pathology University of Fukui Fukui Japan
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Papillary muscle tissue embolism causing myocardial infarction after minimally invasive mitral valve repair: a case report
Background: Perioperative myocardial infarction after minimally invasive mitral valve surgery is uncommon. Recognized mechanisms include iatrogenic circumflex coronary injury and coronary embolism, but embolization of papillary muscle tissue has not been well described. Case summary: A 76-year-old woman underwent minimally invasive mitral valve repair for severe mitral regurgitation caused by P3 prolapse. Inferior ST-segment elevation developed after aortic unclamping and persisted despite repeated de-airing. Because the patient remained haemodynamically stable and transoesophageal echocardiography did not show a definite new regional wall-motion abnormality, she was initially observed closely. Persistent ST-segment elevation and mild lateral wall hypokinesis two hours after intensive care unit admission prompted emergency coronary angiography, which demonstrated complete occlusion of the posterolateral branch of the left circumflex coronary artery. Aspiration thrombectomy restored Thrombolysis In Myocardial Infarction grade 3 flow. Histopathological examination of the retrieved material showed that all identifiable tissue fragments consisted of striated cardiac muscle, supporting papillary muscle tissue embolism. The patient recovered without residual regional wall-motion abnormality. Discussion: Papillary muscle tissue can be disrupted during subvalvular manipulation and embolize to a coronary artery after restoration of forward flow. Persistent or recurrent ST-segment elevation after mitral valve surgery should prompt early coronary angiography even when air embolism is initially suspected and haemodynamics remain stable.
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Open AccessPapillary muscle tissue embolism causing myocardial infarction after minimally invasive mitral valve repair: a case report
Background: Perioperative myocardial infarction after minimally invasive mitral valve surgery is uncommon. Recognized mechanisms include iatrogenic circumflex coronary injury and coronary embolism, but embolization of papillary muscle tissue has not been well described. Case summary: A 76-year-old woman underwent minimally invasive mitral valve repair for severe mitral regurgitation caused by P3 prolapse. Inferior ST-segment elevation developed after aortic unclamping and persisted despite repeated de-airing. Because the patient remained haemodynamically stable and transoesophageal echocardiography did not show a definite new regional wall-motion abnormality, she was initially observed closely. Persistent ST-segment elevation and mild lateral wall hypokinesis two hours after intensive care unit admission prompted emergency coronary angiography, which demonstrated complete occlusion of the posterolateral branch of the left circumflex coronary artery. Aspiration thrombectomy restored Thrombolysis In Myocardial Infarction grade 3 flow. Histopathological examination of the retrieved material showed that all identifiable tissue fragments consisted of striated cardiac muscle, supporting papillary muscle tissue embolism. The patient recovered without residual regional wall-motion abnormality. Discussion: Papillary muscle tissue can be disrupted during subvalvular manipulation and embolize to a coronary artery after restoration of forward flow. Persistent or recurrent ST-segment elevation after mitral valve surgery should prompt early coronary angiography even when air embolism is initially suspected and haemodynamics remain stable.
- Open Access
- 5 November 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (6)
Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report
Introduction: Perivascular epithelioid cell neoplasms originating in the urinary bladder are rare, and their standard treatment methods have not been established. Case Presentation: A 14‐year‐old girl with intermittent macroscopic hematuria was referred to our hospital. Ultrasonography and magnetic resonance imaging revealed a 5 cm spherical mass in the bladder neck and transurethral biopsy revealed a perivascular epithelioid cell neoplasm. Chromosome G‐banding analysis indicated a transcription factor E3 gene rearrangement. The mTOR inhibitor, sirolimus, was administered for six months, followed by partial cystectomy. No tumor recurrence was observed after 15 months. Conclusion: This case suggests the potential efficacy of partial cystectomy combined with neoadjuvant mTOR inhibitor therapy for transcription factor E3 gene rearrangement‐positive perivascular epithelioid cell neoplasms.
- 5 November 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (6)
Open AccessBladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report
Introduction: Perivascular epithelioid cell neoplasms originating in the urinary bladder are rare, and their standard treatment methods have not been established. Case Presentation: A 14‐year‐old girl with intermittent macroscopic hematuria was referred to our hospital. Ultrasonography and magnetic resonance imaging revealed a 5 cm spherical mass in the bladder neck and transurethral biopsy revealed a perivascular epithelioid cell neoplasm. Chromosome G‐banding analysis indicated a transcription factor E3 gene rearrangement. The mTOR inhibitor, sirolimus, was administered for six months, followed by partial cystectomy. No tumor recurrence was observed after 15 months. Conclusion: This case suggests the potential efficacy of partial cystectomy combined with neoadjuvant mTOR inhibitor therapy for transcription factor E3 gene rearrangement‐positive perivascular epithelioid cell neoplasms.
- 28 August 2026
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 74 (6) , 651-665
Immunohistochemical Characterization of Keratan Sulfate Preferentially Expressed in Papillary Thyroid Carcinoma Using a Novel Monoclonal Antibody 299-1C1
Keratan sulfate (KS) is a glycosaminoglycan consisting of repeating N -acetyllactosamine disaccharides, in which both galactose and N -acetylglucosamine are often 6- O -sulfated. It has been reported that KS recognized by the monoclonal antibodies 5D4 and 373E1 is preferentially expressed in papillary thyroid carcinoma (PTC) and only minimally in other thyroid tumors/lesions or normal thyroid tissue. However, the precise epitopes recognized by these antibodies remain incompletely characterized, and the expression and extent of low-sulfated KS in PTC have not been systematically evaluated. To better understand the nature of KS expressed in PTC, we generated a novel anti-KS monoclonal antibody, 299-1C1, and performed immunohistochemical analyses using 299-1C1 together with two existing anti-KS monoclonal antibodies, 5D4 and R-10G, in combination with keratanase II and endo-β-galactosidase. The results showed that both highly sulfated and low-sulfated KS are preferentially expressed in PTC, including lymph node metastases, accompanied by upregulation of genes encoding key KS biosynthetic enzymes ( B3GNT7 , B4GALT4 , CHST2 , and CHST6 ) in integrated TCGA/GTEx transcriptomic datasets. Expression of B3GNT7 , B4GALT4 , and CHST2 , but not CHST6 , was further increased in BRAF -mutant PTCs. These findings indicate that anti-KS monoclonal antibodies are useful for the pathological diagnosis of PTC, particularly for distinguishing lymph node metastases from intranodal thyroid inclusions.
- 28 August 2026
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 74 (6) , 651-665
Immunohistochemical Characterization of Keratan Sulfate Preferentially Expressed in Papillary Thyroid Carcinoma Using a Novel Monoclonal Antibody 299-1C1
Keratan sulfate (KS) is a glycosaminoglycan consisting of repeating N -acetyllactosamine disaccharides, in which both galactose and N -acetylglucosamine are often 6- O -sulfated. It has been reported that KS recognized by the monoclonal antibodies 5D4 and 373E1 is preferentially expressed in papillary thyroid carcinoma (PTC) and only minimally in other thyroid tumors/lesions or normal thyroid tissue. However, the precise epitopes recognized by these antibodies remain incompletely characterized, and the expression and extent of low-sulfated KS in PTC have not been systematically evaluated. To better understand the nature of KS expressed in PTC, we generated a novel anti-KS monoclonal antibody, 299-1C1, and performed immunohistochemical analyses using 299-1C1 together with two existing anti-KS monoclonal antibodies, 5D4 and R-10G, in combination with keratanase II and endo-β-galactosidase. The results showed that both highly sulfated and low-sulfated KS are preferentially expressed in PTC, including lymph node metastases, accompanied by upregulation of genes encoding key KS biosynthetic enzymes ( B3GNT7 , B4GALT4 , CHST2 , and CHST6 ) in integrated TCGA/GTEx transcriptomic datasets. Expression of B3GNT7 , B4GALT4 , and CHST2 , but not CHST6 , was further increased in BRAF -mutant PTCs. These findings indicate that anti-KS monoclonal antibodies are useful for the pathological diagnosis of PTC, particularly for distinguishing lymph node metastases from intranodal thyroid inclusions.
- 30 June 2026
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 48 (10) , e103-e108
Basal Cell Carcinosarcoma with an Osteosarcomatous Component: A Case Report Supporting the Diagnostic Utility of SATB2 and TRAP Immunostaining with a Literature Review of 22 Cases
Basal cell carcinoma rarely coexists with malignant mesenchymal component(s), termed as basal cell carcinosarcoma (BCCS). BCCS often comprises an osteosarcomatous change, which considerably varies in the histological extent among reported cases. Owing to its rarity and morphological heterogeneity, the disease may be underrecognized and pose accurate diagnosis and treatment approaches. In this study, we present a case of BCCS with a focal osteosarcomatous component in a 91-year-old woman with a rapidly enlarging solitary tumor on the left cheek. Histopathological examination revealed a biphasic tumor composed of conventional basal cell carcinoma and a high-grade sarcomatous component, both of which were intermingled gradually in the transitional zone. Limited portions of the sarcomatous component contained atypical spindle-to oval-shaped cells and osteoclast-like multinucleated giant cells surrounded by an osteoid matrix. Immunohistochemically, these cells were positive for an osteoblastic marker SATB2 and an osteoclast-associated marker tartrate-resistant acid phosphatase, respectively, but negative for epithelial markers AE1/AE3 and BerEP4. These findings supported a diagnosis of BCCS with an osteosarcomatous component. To the best of our knowledge, literature review identified only 21 similar cases thus far reported, but no previous reports have used a combined use of SATB2 and tartrate-resistant acid phosphatase immunostaining to substantiate the osteosarcomatous focus in cutaneous carcinosarcoma. Our case may highlight the potential diagnostic value of these 2 markers in distinguishing the true osteosarcomatous components from mimicking elements such as dystrophic calcification or hyalinized collagen deposition, but also in detecting a subtle osteosarcomatous component in carcinosarcoma.
- 30 June 2026
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 48 (10) , e103-e108
Basal Cell Carcinosarcoma with an Osteosarcomatous Component: A Case Report Supporting the Diagnostic Utility of SATB2 and TRAP Immunostaining with a Literature Review of 22 Cases
Basal cell carcinoma rarely coexists with malignant mesenchymal component(s), termed as basal cell carcinosarcoma (BCCS). BCCS often comprises an osteosarcomatous change, which considerably varies in the histological extent among reported cases. Owing to its rarity and morphological heterogeneity, the disease may be underrecognized and pose accurate diagnosis and treatment approaches. In this study, we present a case of BCCS with a focal osteosarcomatous component in a 91-year-old woman with a rapidly enlarging solitary tumor on the left cheek. Histopathological examination revealed a biphasic tumor composed of conventional basal cell carcinoma and a high-grade sarcomatous component, both of which were intermingled gradually in the transitional zone. Limited portions of the sarcomatous component contained atypical spindle-to oval-shaped cells and osteoclast-like multinucleated giant cells surrounded by an osteoid matrix. Immunohistochemically, these cells were positive for an osteoblastic marker SATB2 and an osteoclast-associated marker tartrate-resistant acid phosphatase, respectively, but negative for epithelial markers AE1/AE3 and BerEP4. These findings supported a diagnosis of BCCS with an osteosarcomatous component. To the best of our knowledge, literature review identified only 21 similar cases thus far reported, but no previous reports have used a combined use of SATB2 and tartrate-resistant acid phosphatase immunostaining to substantiate the osteosarcomatous focus in cutaneous carcinosarcoma. Our case may highlight the potential diagnostic value of these 2 markers in distinguishing the true osteosarcomatous components from mimicking elements such as dystrophic calcification or hyalinized collagen deposition, but also in detecting a subtle osteosarcomatous component in carcinosarcoma.
- 29 December 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 73 (1-2) , 55-61
Expression of Glycoprotein 2 and Its Glycosylation in Human Cowper’s Gland
Glycoprotein 2 (GP2), initially identified as a primary membrane protein of zymogen granules in pancreatic acinar cells, is a marker of intestinal microfold cells (M cells) and involved in bacterial transcytosis in M cells. Recent studies have reported GP2 expression in the pancreas and intestine among various other organs. We aimed to elucidate the expression of GP2 and its glycosylation modifications in human Cowper’s glands. We generated an anti-human GP2 monoclonal antibody suitable for formalin-fixed, paraffin-embedded tissue sections. This antibody, designated GP2-71, successfully stained both the plasma membrane and cytoplasm of normal pancreatic acinar cells. Subsequently, we performed GP2-71 immunostaining on normal human Cowper’s gland tissues. Our findings revealed that the luminal cell membrane and contents of the Cowper’s glands reacted strongly with GP2-71. Moreover, the regions stained with GP2-71 were partially immunostained with the anti-sialyl Lewis x (sLex) monoclonal antibody HECA-452. Furthermore, western blot analysis of protein A-purified GP2-immunoglobulin G fusion proteins demonstrated that GP2 was decorated with HECA-452-positive glycans. Collectively, these findings indicate that GP2 is expressed in human Cowper’s glands and is potentially decorated with sLex-related glycans.
- 29 December 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 73 (1-2) , 55-61
Expression of Glycoprotein 2 and Its Glycosylation in Human Cowper’s Gland
Glycoprotein 2 (GP2), initially identified as a primary membrane protein of zymogen granules in pancreatic acinar cells, is a marker of intestinal microfold cells (M cells) and involved in bacterial transcytosis in M cells. Recent studies have reported GP2 expression in the pancreas and intestine among various other organs. We aimed to elucidate the expression of GP2 and its glycosylation modifications in human Cowper’s glands. We generated an anti-human GP2 monoclonal antibody suitable for formalin-fixed, paraffin-embedded tissue sections. This antibody, designated GP2-71, successfully stained both the plasma membrane and cytoplasm of normal pancreatic acinar cells. Subsequently, we performed GP2-71 immunostaining on normal human Cowper’s gland tissues. Our findings revealed that the luminal cell membrane and contents of the Cowper’s glands reacted strongly with GP2-71. Moreover, the regions stained with GP2-71 were partially immunostained with the anti-sialyl Lewis x (sLex) monoclonal antibody HECA-452. Furthermore, western blot analysis of protein A-purified GP2-immunoglobulin G fusion proteins demonstrated that GP2 was decorated with HECA-452-positive glycans. Collectively, these findings indicate that GP2 is expressed in human Cowper’s glands and is potentially decorated with sLex-related glycans.
- 10 October 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (11-12) , 683-692
High M2/M1 Macrophage Ratio Observed in Nasal Polyps Formed in Allergic Fungal Rhinosinusitis
Allergic fungal rhinosinusitis (AFRS) shares similarities with eosinophilic chronic rhinosinusitis (ECRS), both characterized by intractable nasal polyps. The key distinction lies in the presence of fungal infection within the nasal cavity. While ECRS nasal polyps are known for significant infiltration of M2 macrophages and eosinophils, as well as an increase in high endothelial venule (HEV)-like vessels, these features are less commonly reported in AFRS. This study compared clinicopathological findings between AFRS ( n=10), ECRS ( n=12), and non-ECRS ( n=10) patients’ nasal polyps using immunohistochemical analysis for CD163 and CD68 to assess the M2/M1 macrophage ratio, and peripheral lymph node addressin (PNAd) and CD34 to evaluate the proportion of HEV-like vessels. AFRS showed a significantly higher number of CD163-positive M2 macrophages and an increased M2/M1 ratio compared with ECRS. However, the percentage of HEV-like vessels and the number of eosinophils infiltrating the nasal polyps were similar in both AFRS and ECRS. The observed increase in M2 macrophages in AFRS nasal polyps is presumed to be induced by fungal infection in the nasal cavity, in comparison with ECRS. These results highlight the distinctive immunological profiles of AFRS and ECRS, emphasizing the role of macrophage polarization in their pathogenesis.
- 10 October 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (11-12) , 683-692
High M2/M1 Macrophage Ratio Observed in Nasal Polyps Formed in Allergic Fungal Rhinosinusitis
Allergic fungal rhinosinusitis (AFRS) shares similarities with eosinophilic chronic rhinosinusitis (ECRS), both characterized by intractable nasal polyps. The key distinction lies in the presence of fungal infection within the nasal cavity. While ECRS nasal polyps are known for significant infiltration of M2 macrophages and eosinophils, as well as an increase in high endothelial venule (HEV)-like vessels, these features are less commonly reported in AFRS. This study compared clinicopathological findings between AFRS ( n=10), ECRS ( n=12), and non-ECRS ( n=10) patients’ nasal polyps using immunohistochemical analysis for CD163 and CD68 to assess the M2/M1 macrophage ratio, and peripheral lymph node addressin (PNAd) and CD34 to evaluate the proportion of HEV-like vessels. AFRS showed a significantly higher number of CD163-positive M2 macrophages and an increased M2/M1 ratio compared with ECRS. However, the percentage of HEV-like vessels and the number of eosinophils infiltrating the nasal polyps were similar in both AFRS and ECRS. The observed increase in M2 macrophages in AFRS nasal polyps is presumed to be induced by fungal infection in the nasal cavity, in comparison with ECRS. These results highlight the distinctive immunological profiles of AFRS and ECRS, emphasizing the role of macrophage polarization in their pathogenesis.
- 25 July 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (7) , 453-465
Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma
Summary We previously demonstrated that among various histological types of human testicular germinal cell tumors (GCTs), embryonal carcinoma (EC) preferentially expresses low-sulfated keratan sulfate (KS) consisting of repeating N-acetyllactosamine (LacNAc) disaccharide units composed of galactose and 6- O-sulfated N-acetylglucosamine (GlcNAc), which is recognized by the R-10G antibody. Recently, we generated another anti-low-sulfated KS monoclonal antibody, 294-1B1. Immunohistochemical analysis of testicular GCTs ( n=83) revealed that the low-sulfated KS recognized by 294-1B1 is also preferentially expressed in EC but minimally in other GCT histological types. Moreover, immunolabeling with R-10G and 294-1B1 antibodies was resistant to peptide- N-glycosidase F digestion, and EC was not stained with the MECA-79 antibody, indicating that low-sulfated KS expressed in EC contains mucin-type core 2 O-glycans carrying GlcNAc-6- O-sulfated oligo-LacNAc. Double immunofluorescence staining showed that R-10G and 294-1B1 antibody signals colocalized with those for podocalyxin (PODXL). Furthermore, western blot analysis of recombinant human PODXL•IgG fusion proteins secreted from low-sulfated KS-expressing human embryonic kidney 293T cells revealed that PODXL functions as a core protein for low-sulfated KS. Taken together, these findings strongly suggest that the PODXL glycoform decorated with low-sulfated KS is preferentially expressed in human testicular EC and may therefore serve as a diagnostic marker for this malignancy
- 25 July 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (7) , 453-465
Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma
Summary We previously demonstrated that among various histological types of human testicular germinal cell tumors (GCTs), embryonal carcinoma (EC) preferentially expresses low-sulfated keratan sulfate (KS) consisting of repeating N-acetyllactosamine (LacNAc) disaccharide units composed of galactose and 6- O-sulfated N-acetylglucosamine (GlcNAc), which is recognized by the R-10G antibody. Recently, we generated another anti-low-sulfated KS monoclonal antibody, 294-1B1. Immunohistochemical analysis of testicular GCTs ( n=83) revealed that the low-sulfated KS recognized by 294-1B1 is also preferentially expressed in EC but minimally in other GCT histological types. Moreover, immunolabeling with R-10G and 294-1B1 antibodies was resistant to peptide- N-glycosidase F digestion, and EC was not stained with the MECA-79 antibody, indicating that low-sulfated KS expressed in EC contains mucin-type core 2 O-glycans carrying GlcNAc-6- O-sulfated oligo-LacNAc. Double immunofluorescence staining showed that R-10G and 294-1B1 antibody signals colocalized with those for podocalyxin (PODXL). Furthermore, western blot analysis of recombinant human PODXL•IgG fusion proteins secreted from low-sulfated KS-expressing human embryonic kidney 293T cells revealed that PODXL functions as a core protein for low-sulfated KS. Taken together, these findings strongly suggest that the PODXL glycoform decorated with low-sulfated KS is preferentially expressed in human testicular EC and may therefore serve as a diagnostic marker for this malignancy